Drugs Health Pharma

Global diabetic population rose fourfold to 828 million in 2022

The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,

Read More
Health

Researchers develop innovative non-addictive painkiller for chronic pain

HQ Team November 13, 2024: A team of international researchers has developed a non-addictive painkiller that remains inactive until it reaches sites of

Read More
Climate

Multilateral development banks pledge $120b to climate finance

HQ Team November 13, 2024: At COP29 in Baku, Azerbaijan, multilateral development banks (MBDs) announced a commitment to $120 billion in climate financing

Read More
Pharma

Danish Pharma ALK pays ARS $145m for Neffy nasal spray licensing deal

HQ Team November 13, 2024: ALK-Abelló, the Danish pharma company has acquired exclusive rights to Neffy (epinephrine nasal spray) from ARS Pharmaceuticals for

Read More
Climate Health Medical

Tax fossil fuel extraction, aviation, shipping: UN chief says at COP29

UN Secretary-General António Guterres outlined a three-point plan to limit global temperature rise to 1.5 degrees Celsius by 2030, including new ways to

Read More
Health Medical Opinion

Opinion: Take life head-on; forced positivity is fake confidence

Toxic positivity promotes the belief that individuals should maintain happiness regardless of their circumstances. It discourages negative thoughts, even in situations that naturally

Read More
Drugs Health Pharma

US drug regulator removes clinical hold on Novavax’s vaccines

Novovax Inc., will soon start enrollment for end-stage trials of its Covid-19-Influenza vaccine and stand-alone influenza jab following a nod from the US

Read More
Drugs Health Pharma

AstraZeneca to invest $3.5 billion in the US to expand global footprint

Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of

Read More
Drugs Health Pharma

AbbVie says schizophrenic drug fails in 2 mid-stage experimental trials

AbbVie Inc.’s two mid-stage trials of an investigational schizophrenia drug have failed to meet its primary goal, according to a company statement.

Read More
Drugs Health Pharma

WHO to convene emergency meeting on mpox on November 22

The World Health Organization will hold an emergency meeting on November 22 to decide whether mpox continues to be a public health emergency

Read More